Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
GLUCOSE ANHYDROUS SODIUM CHLORIDE SODIUM LACTATE CALCIUM CHLORIDE DIHYDRATE MAGNESIUM CHLORIDE HEXAHYDRATE
Fresenius Medical Care Deutschland GmbH
Solution for Dialysis
2011-07-22
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gambrosol trio 40, solution for peritoneal dialysis. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Gambrosol trio 40 is filled in a three-compartment bag. Two smaller compartments (A and B) each contain 50% glucose solution and sodium chloride (NaCl) and a larger third compartment (C) the electrolyte solution. After breaking the frangible pin between compartments A and C and thoroughly mixing the two fluids a PD solution containing 1.5% glucose will be produced. Similarly mixing the contents of compartments B and C will produce a PD solution containing 2.5% glucose. Finally by breaking both frangible pins and mixing the contents of all three compartments will produce a solution containing 3.9% glucose. _BEFORE RECONSTITUTION_ _EACH 1000 ML CONTAINS:_ GLUCOSE COMPARTMENTS A AND B ELECTROLYTE COMPARTMENT C _AFTER RECONSTITUTION_ The glucose compartments A or/and B are mixed with the electrolyte compartment C to give the following reconstituted solutions: _ELECTROLYTE CONTENT PER EACH 1000 ML OF RECONSTITUTED SOLUTION:_ ACTIVE INGREDIENTS: Glucose anhydrous 500.0 g _(as glucose monohydrate_ _550.0 g)_ Sodium chloride 5.38 g ACTIVE INGREDIENTS: Sodium chloride 5.38 g Sodium lactate S-(+) anhydrous 4.72 g _(as 60% m/m solution)_ _(7.87 g)_ Calcium chloride dihydrate 0.209 g Magnesium chloride hexahydrate 0.054 g Mix compartments A and C Reconstituted solution 40L (Light) Mix compartments B and C Reconstituted solution 40M (Medium) Mix compartments A, B and C Reconstituted solution 40H (High) RECONSTITUTED SOLUTION MMOL/L L M H Sodium Na + 133 132 131 mmol/l Calcium Ca ++ 1.38 1.35 1.31 mmol/l Magnesium Mg ++ 0.26 0.25 0.24 mmol/l Chloride Cl - 95.4 95.2 95.2 mmol/l Lactate 41 40 39 mmol/l IRISH MEDICINES BOARD _______________________________________________ Read the complete document